上海医药产业与医疗服务业融合发展的现状、问题与对策  

The Current Situation, Problems and Countermeasures of the Integrated Development of Shanghai Pharmaceutical Industry and Medical Service Industry

作　　者：许明飞 康琦 Xu Mingfei;Kang Qi

机构地区：[1]上海市卫生和健康发展研究中心,200031

出　　处：《科学发展》2022年第10期15-22,共8页Scientific Development

摘　　要：要以国际最高标准、最好水平为标杆,瞄准医学科技创新和生物医药产业发展,营造良好的医学科技创新生态环境。打造3~5家国际一流的研究型医院,建设一批医企融合发展示范基地,培育一批在国际临床科技创新前沿占有一席之地的医学科学家,实现上海牵头的国际和国内多中心临床试验数量在国内领先。支持发展一批创新医药企业,产出一批新规范、新指南、新技术、新材料、新器械、新设备、新药物等,支撑生物医药产业集群高质量发展。To take the highest international standard and best level as the benchmark, we should aim at medical science and technology innovation and biomedical industry development, and create a good ecological environment for medical science and technology innovation.We should create 3 to 5 international first-class research hospitals, build a number of demonstration bases for the integration and development of medical enterprises, cultivate a number of medical scientists who occupy a place at the forefront of international clinical science and technology innovation, and realize the leading number of international and domestic multi-center clinical trials led by Shanghai in China. We should upport the development of a number of innovative pharmaceutical enterprises, output a number of new specifications, new guidelines, new technologies, new materials, new devices, new equipment, new drugs, etc., to support the high-quality development of Biopharmaceutical industry clusters.

关 键 词：医药产业 医疗服务业 融合发展 

分 类 号：F127.51[经济管理—世界经济]